Abiopharma

Powerfleet to Attend June Investor Conferences

Cuprina Holdings Announces Completion of Reverse Stock Split and Requests a Hearing before the Nasdaq Hearings Panel to Maintain Listing

Kun Peng International Ltd. Announces 1-for-10 Reverse Stock Split

Clinical trial NCT06630299 updates: 1. primary completion date: 2026-04-01 → 2026-04-23 2. enrollment: not set → 600 participants

Clinical trial NCT06846671: enrollment: not set → 250 participants.

Clinical trial NCT06952530 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: not set → 487 participants

Clinical trial NCT04097145: enrollment: not set → 1270 participants.

Clinical trial NCT01915212: enrollment: not set → 69 participants.

Clinical trial NCT07043400: enrollment: not set → 351 participants.

Clinical trial NCT07604701: enrollment: not set → 226 participants.